Solventum Corp Files 8-K on Security Holder Votes

Ticker: SOLV · Form: 8-K · Filed: 2025-05-02T00:00:00.000Z

Sentiment: neutral

Topics: corporate-action, filing, shareholder-vote

Related Tickers: MMM

TL;DR

Solventum Corp (formerly 3M Health Care) filed an 8-K for shareholder votes on April 30th.

AI Summary

Solventum Corporation, formerly 3M Health Care Co., filed an 8-K on May 2, 2025, reporting matters submitted to a vote of security holders as of April 30, 2025. The company, incorporated in Delaware, is headquartered at 3M Center, St. Paul, MN, and operates in the Surgical & Medical Instruments & Apparatus industry.

Why It Matters

This filing indicates that Solventum Corporation is proceeding with corporate actions requiring shareholder approval, a standard step for companies undergoing significant structural changes or strategic initiatives.

Risk Assessment

Risk Level: low — This is a routine corporate filing related to shareholder votes, not indicating any immediate financial distress or significant operational change.

Key Numbers

Key Players & Entities

FAQ

What specific matters were submitted to a vote of security holders?

The filing does not specify the exact matters submitted to a vote of security holders, only that such matters were reported as of April 30, 2025.

When was Solventum Corporation formerly known as?

Solventum Corporation was formerly known as 3M Health Care Co.

In which state is Solventum Corporation incorporated?

Solventum Corporation is incorporated in Delaware.

What is the principal executive office address of Solventum Corporation?

The principal executive offices are located at 3M Center, Building 275-6W, 2510 Conway Avenue East, Maplewood, Minnesota 55144.

What is the SIC code for Solventum Corporation?

The Standard Industrial Classification (SIC) code for Solventum Corporation is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.

From the Filing

0001964738-25-000043.txt : 20250502 0001964738-25-000043.hdr.sgml : 20250502 20250502161215 ACCESSION NUMBER: 0001964738-25-000043 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20250430 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20250502 DATE AS OF CHANGE: 20250502 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Solventum Corp CENTRAL INDEX KEY: 0001964738 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 922008841 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41968 FILM NUMBER: 25908661 BUSINESS ADDRESS: STREET 1: C/O 3M COMPANY STREET 2: 3M CENTER, BUILDING 275-6W-02 CITY: ST. PAUL STATE: MN ZIP: 55144-1000 BUSINESS PHONE: 651-733-1110 MAIL ADDRESS: STREET 1: C/O 3M COMPANY STREET 2: 3M CENTER, BUILDING 275-6W-02 CITY: ST. PAUL STATE: MN ZIP: 55144-1000 FORMER COMPANY: FORMER CONFORMED NAME: 3M Health Care Co DATE OF NAME CHANGE: 20230203 8-K 1 solv-20250430.htm 8-K solv-20250430 FALSE 0001964738 0001964738 2025-02-27 2025-02-27 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 30, 2025 SOLVENTUM CORPORATION (Exact Name of Registrant as Specified in Its Charter) Delaware File No. 001-41968 92-2008841 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 3M Center, Building 275-6W 2510 Conway Avenue East , Maplewood , Minnesota 55144 (Address of Principal Executive Offices) (Zip Code) (Registrant’s Telephone Number, Including Area Code) ( 651 ) 733-1110 Not Applicable (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, Par Value $.01 Per Share SOLV New York Stock Exchange Securities registered pursuant to section 12(g) of the Act: None Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company      ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the exchange Act.     ☐ Item 5.07 Submission of Matters to a Vote of Security Holders. Solventum Corporation (“Solventum”) held its annual meeting of shareholders on April 30, 2025. Set forth below are the final voting results for each of the matters submitted to a vote of the shareholders. For more information about the proposals set forth below, please see our definitive proxy statement filed with the U.S. Securities and Exchange Commission on March 21, 2025 (“Proxy Statement”). Proposal Number 1: The shareholders elected each of the four Class I nominees to the Board of Directo

View on Read The Filing